444685
Platinum
wire, diam. 2.0 mm, 99.9% trace metals basis
Synonym(s):
Platinum black, Platinum element, Platinum gray
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Empirical Formula (Hill Notation):
Pt
CAS Number:
Molecular Weight:
195.08
EC Number:
MDL number:
UNSPSC Code:
12141734
PubChem Substance ID:
NACRES:
NA.23
Recommended Products
assay
99.9% trace metals basis
form
wire
resistivity
10.6 μΩ-cm, 20°C
diam.
2.0 mm
bp
3827 °C (lit.)
mp
1772 °C (lit.)
density
21.45 g/cm3 (lit.)
SMILES string
[Pt]
InChI
1S/Pt
InChI key
BASFCYQUMIYNBI-UHFFFAOYSA-N
Related Categories
General description
Platinum (Pt) wire is a metal wire that is a biocompatible material that can be used in electrodes and implants. The efficiency of the platinum electrode can be improved by forming a platinum black surface.
Quantity
1.4 g = 2 cm; 7 g = 10 cm
Storage Class
13 - Non Combustible Solids
wgk_germany
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Electrodes
Bioimpedance and Bioelectricity Basics, 179-254 (2015)
Electrode array design and fabrication for implantable systems
Implantable Sensor Systems for Medical Applications, 249(13-14), 150-182 (2013)
Synthesis of novel ruthenium sensitizers and their application in dye-sensitized solar cells
Nazeeruddin MK, et al.
Coordination Chemistry Reviews, 249(13-14), 1460-1467 (2005)
Shanshan Cui et al.
BMC structural biology, 13, 4-4 (2013-03-23)
To explore novel platinum-based anticancer agents that are distinct from the structure and interaction mode of the traditional cisplatin by forming the bifunctional intrastrand 1,2 GpG adduct, the monofunctional platinum+DNA adducts with extensive non-covalent interactions had been studied. It was
Hiroaki Akamatsu et al.
Japanese journal of clinical oncology, 43(6), 664-668 (2013-04-16)
Interstitial lung disease associated with gefitinib is a critical adverse reaction. When geftinib was administered to EGFR-unknown patients, the interstitial lung disease incidence rate was approximately 3-4% in Japan, and usually occurs during the first 4 weeks of treatment. However
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service